SMIM30 influences HCC progression by binding to SRC/YES1, which drives its phosphorylation and membrane anchoring, promoting the downstream ERK1/2 and p38 MAPK signaling pathways [81]. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.